Coronavirus vaccine trials in China to start in April - Breaking The News

Coronavirus vaccine trials in China to start in April

16 March

1 min read

EPA-EFE/HOTLI SIMANJUNTAK

German biotechnology company BioNTech and Chinese pharmaceutical firm Fosun Pharma are set to start clinical tests and trials for the coronavirus vaccine in China by late April, the companies unveiled on Monday.

"Fosun Pharma will commercialize the vaccine in China upon regulatory approval, with BioNTech retaining full rights to develop and commercialize the vaccine in the rest of the world," BioNTech said in a statement.

Fosun Pharma will pay up to $135 million in upfront and potential future investment and milestone payments to the German company while the two firms will share future gross profits from the sale of the vaccine in China.

coronavirus covid-19 impact coronavirus vaccine

Related Stocks

SSE Composite Index

Yellen links COVID-19 stimulus to slight inflation rise

8 January

United States Treasury Secretary Janet Yellen stated on Wednesday that economic relief measures during the Biden administration may have contributed modestly to the nation’s inflation rise.In an interview on CNBC, the outgoing secretary acknowledged a possible link between pandemic stimulus spending and inflation, which she said increased "a little bit." However, she emphasized that the primary driver of inflation was the impact of COVID-19 itself.Yellen...

WHO urges China for COVID-19 origin data after 5 years

30 December

The World Health Organization (WHO) has reiterated its appeal to China for data and access to determine the origins of COVID-19, calling it a "moral and scientific imperative." In a statement on Monday, the organization emphasized that transparency, sharing, and international cooperation are essential to prevent and prepare for future pandemics.The statement comes as the world marks five years since COVID-19 emerged in Wuhan, China. WHO echoed its...

Harris slams Trump for 'admiring dictators'

22 October

United States Vice President Kamala Harris, the Democratic presidential nominee, spoke in a recent NBC News interview about the choice Americans face in the upcoming election. She contrasted herself with former President Donald Trump, saying that voters must decide whether they want a leader who she claims openly admires authoritarian figures or not. "The American people are being presented with a choice here about whether we want a president who...

Moderna sued for patent infringement over COVID-19 vaccines

17 October

Northwestern University launched a lawsuit against Modern Inc. in Delaware federal court, accusing it of using the university's innovations to roll out its COVID-19 vaccine, Spikevax, without a license.Northwestern stressed that Moderna completed the first clinical trial of its COVID-19 vaccine a month before the World Health Organization declared the coronavirus outbreak a pandemic, adding that the pharmaceutical company "could not have achieved this...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.